Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice

Carlton C. Barnett, Adam W. Beck, Shane E. Holloway, Marguerite Kehler, Marie K. Schluterman, Rolf A. Brekken, Jason B. Fleming, Christopher C. Silliman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

BACKGROUND: Perioperative blood transfusion in pancreatic cancer patients has been linked to decreased survival; however, a causal mechanism has not been determined. During the processing and storage of packed erythrocytes, biologically active molecules accumulated in the acellular plasma fraction; therefore, the authors hypothesized that the plasma fraction of stored packed erythrocytes promoted tumor progression. METHODS: Proliferation and migration of murine pancreatic cancer and control cells were determined in vitro in response to the plasma fraction from leukocyte and nonleukocyte-reduced fresh versus stored packed erythrocytes. Last, an immunocompetent murine model was used to assess the effect of the plasma fraction of stored and processed packed erythrocytes on pancreatic cancer progression. RESULTS: Incubation of pancreatic cancer cells with the plasma fraction of packed erythrocytes increased proliferation and migration. Intravenous delivery of the acellular plasma fraction to mice with pancreatic cancer significantly increased the tumor weight in both leukocyte-reduced and nonleukocyte-reduced packed-erythrocyte groups (P < .01), although tumor growth and morbidity were greatest in the nonleukocyte-reduced group. CONCLUSIONS: The plasma fraction of stored packed erythrocytes promoted murine pancreatic cancer proliferation and migration in vitro and when administered intravenously, significantly augmented pancreatic cancer growth in immunocompetent mice.

Original languageEnglish (US)
Pages (from-to)3862-3874
Number of pages13
JournalCancer
Volume116
Issue number16
DOIs
StatePublished - Aug 15 2010

Fingerprint

Pancreatic Neoplasms
Erythrocytes
Growth
Leukocytes
Plasma Cells
Tumor Burden
Blood Transfusion
Neoplasms
Morbidity
Survival

Keywords

  • Erythrocytes
  • Immunomodulation
  • Metastasis
  • Pancreatic cancer
  • Proliferation
  • Transfusion

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Barnett, C. C., Beck, A. W., Holloway, S. E., Kehler, M., Schluterman, M. K., Brekken, R. A., ... Silliman, C. C. (2010). Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. Cancer, 116(16), 3862-3874. https://doi.org/10.1002/cncr.25140

Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. / Barnett, Carlton C.; Beck, Adam W.; Holloway, Shane E.; Kehler, Marguerite; Schluterman, Marie K.; Brekken, Rolf A.; Fleming, Jason B.; Silliman, Christopher C.

In: Cancer, Vol. 116, No. 16, 15.08.2010, p. 3862-3874.

Research output: Contribution to journalArticle

Barnett, CC, Beck, AW, Holloway, SE, Kehler, M, Schluterman, MK, Brekken, RA, Fleming, JB & Silliman, CC 2010, 'Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice', Cancer, vol. 116, no. 16, pp. 3862-3874. https://doi.org/10.1002/cncr.25140
Barnett, Carlton C. ; Beck, Adam W. ; Holloway, Shane E. ; Kehler, Marguerite ; Schluterman, Marie K. ; Brekken, Rolf A. ; Fleming, Jason B. ; Silliman, Christopher C. / Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. In: Cancer. 2010 ; Vol. 116, No. 16. pp. 3862-3874.
@article{e9982e3f5575449da79a6fc2e9f40072,
title = "Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice",
abstract = "BACKGROUND: Perioperative blood transfusion in pancreatic cancer patients has been linked to decreased survival; however, a causal mechanism has not been determined. During the processing and storage of packed erythrocytes, biologically active molecules accumulated in the acellular plasma fraction; therefore, the authors hypothesized that the plasma fraction of stored packed erythrocytes promoted tumor progression. METHODS: Proliferation and migration of murine pancreatic cancer and control cells were determined in vitro in response to the plasma fraction from leukocyte and nonleukocyte-reduced fresh versus stored packed erythrocytes. Last, an immunocompetent murine model was used to assess the effect of the plasma fraction of stored and processed packed erythrocytes on pancreatic cancer progression. RESULTS: Incubation of pancreatic cancer cells with the plasma fraction of packed erythrocytes increased proliferation and migration. Intravenous delivery of the acellular plasma fraction to mice with pancreatic cancer significantly increased the tumor weight in both leukocyte-reduced and nonleukocyte-reduced packed-erythrocyte groups (P < .01), although tumor growth and morbidity were greatest in the nonleukocyte-reduced group. CONCLUSIONS: The plasma fraction of stored packed erythrocytes promoted murine pancreatic cancer proliferation and migration in vitro and when administered intravenously, significantly augmented pancreatic cancer growth in immunocompetent mice.",
keywords = "Erythrocytes, Immunomodulation, Metastasis, Pancreatic cancer, Proliferation, Transfusion",
author = "Barnett, {Carlton C.} and Beck, {Adam W.} and Holloway, {Shane E.} and Marguerite Kehler and Schluterman, {Marie K.} and Brekken, {Rolf A.} and Fleming, {Jason B.} and Silliman, {Christopher C.}",
year = "2010",
month = "8",
day = "15",
doi = "10.1002/cncr.25140",
language = "English (US)",
volume = "116",
pages = "3862--3874",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "16",

}

TY - JOUR

T1 - Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice

AU - Barnett, Carlton C.

AU - Beck, Adam W.

AU - Holloway, Shane E.

AU - Kehler, Marguerite

AU - Schluterman, Marie K.

AU - Brekken, Rolf A.

AU - Fleming, Jason B.

AU - Silliman, Christopher C.

PY - 2010/8/15

Y1 - 2010/8/15

N2 - BACKGROUND: Perioperative blood transfusion in pancreatic cancer patients has been linked to decreased survival; however, a causal mechanism has not been determined. During the processing and storage of packed erythrocytes, biologically active molecules accumulated in the acellular plasma fraction; therefore, the authors hypothesized that the plasma fraction of stored packed erythrocytes promoted tumor progression. METHODS: Proliferation and migration of murine pancreatic cancer and control cells were determined in vitro in response to the plasma fraction from leukocyte and nonleukocyte-reduced fresh versus stored packed erythrocytes. Last, an immunocompetent murine model was used to assess the effect of the plasma fraction of stored and processed packed erythrocytes on pancreatic cancer progression. RESULTS: Incubation of pancreatic cancer cells with the plasma fraction of packed erythrocytes increased proliferation and migration. Intravenous delivery of the acellular plasma fraction to mice with pancreatic cancer significantly increased the tumor weight in both leukocyte-reduced and nonleukocyte-reduced packed-erythrocyte groups (P < .01), although tumor growth and morbidity were greatest in the nonleukocyte-reduced group. CONCLUSIONS: The plasma fraction of stored packed erythrocytes promoted murine pancreatic cancer proliferation and migration in vitro and when administered intravenously, significantly augmented pancreatic cancer growth in immunocompetent mice.

AB - BACKGROUND: Perioperative blood transfusion in pancreatic cancer patients has been linked to decreased survival; however, a causal mechanism has not been determined. During the processing and storage of packed erythrocytes, biologically active molecules accumulated in the acellular plasma fraction; therefore, the authors hypothesized that the plasma fraction of stored packed erythrocytes promoted tumor progression. METHODS: Proliferation and migration of murine pancreatic cancer and control cells were determined in vitro in response to the plasma fraction from leukocyte and nonleukocyte-reduced fresh versus stored packed erythrocytes. Last, an immunocompetent murine model was used to assess the effect of the plasma fraction of stored and processed packed erythrocytes on pancreatic cancer progression. RESULTS: Incubation of pancreatic cancer cells with the plasma fraction of packed erythrocytes increased proliferation and migration. Intravenous delivery of the acellular plasma fraction to mice with pancreatic cancer significantly increased the tumor weight in both leukocyte-reduced and nonleukocyte-reduced packed-erythrocyte groups (P < .01), although tumor growth and morbidity were greatest in the nonleukocyte-reduced group. CONCLUSIONS: The plasma fraction of stored packed erythrocytes promoted murine pancreatic cancer proliferation and migration in vitro and when administered intravenously, significantly augmented pancreatic cancer growth in immunocompetent mice.

KW - Erythrocytes

KW - Immunomodulation

KW - Metastasis

KW - Pancreatic cancer

KW - Proliferation

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=77956790922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956790922&partnerID=8YFLogxK

U2 - 10.1002/cncr.25140

DO - 10.1002/cncr.25140

M3 - Article

C2 - 20564095

AN - SCOPUS:77956790922

VL - 116

SP - 3862

EP - 3874

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 16

ER -